VanEck Pharmaceutical ETF
54 hedge funds and large institutions have $62.9M invested in VanEck Pharmaceutical ETF in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
51.71% less ownership
Funds ownership: 79.14% → 27.43% (-52%)
66% less capital invested
Capital invested by funds: $188M → $62.9M (-$125M)
Holders
54
Holding in Top 10
–
Calls
$416K
Puts
$731K
Top Buyers
| 1 | +$2.33M | |
| 2 | +$1.81M | |
| 3 | +$1.21M | |
| 4 |
22CM
20/20 Capital Management
Costa Mesa,
California
|
+$1.13M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$532K |
Top Sellers
| 1 | -$95M | |
| 2 | -$26.3M | |
| 3 | -$13.8M | |
| 4 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
-$4.83M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3.78M |